Comparison of sitafloxacin monotherapy versus doxycycline plus rifampicin for acute uncomplicated human brucellosis: a multicenter, randomized, open-label, non-inferiority trial
{{output}}
Background: Sitafloxacin has demonstrated superior in vitro activity against Brucella species. However, its potential for treating human brucellosis has not been investigated yet. Therefore, this study evaluated and compared the ... ...
